Skip to content
Skip to navigation menu



News Centre

10 Apr 2014

Developing new anti-cancer medicines

 Professor Chris McGuigan

The prospect of four new cancer medicines becoming a reality for patients has taken a huge step forward with the announcement of a £34M investment by a European private biotech company in University research.

ProTide is a platform developed by Professor Chris McGuigan and his team at Cardiff University’s School of Pharmacy and Pharmaceutical Sciences. ProTides are specifically designed to bypass key cancer cell resistance pathways that limit the efficacy of so many of today’s anti-cancer drugs.

Read more

Gene linked to low IQ Gene linked to low IQ


Genetic screening could identify children at risk of low IQ development

First direct evidence of cosmic inflation First direct evidence of cosmic inflation


Cardiff physicists part of international team

Latest News


World's first Community Journalism MOOC

Cardiff University’s new course with FutureLearn

Directory of Expertise: Find experts for media comment

Newsletter advert

Information on strike action

Annual meeting of Court